SELECTA DNA LIMITED

1. Industry Classification

Selecta DNA Limited is classified under SIC Code 80200, which encompasses Security Systems Service Activities. This sector includes the installation, maintenance, and monitoring of security systems, such as intruder alarms, CCTV, access control, and asset marking solutions. The company's name strongly suggests an intended focus on forensic DNA marking—a specialized niche within the broader security market that provides covert asset marking for theft deterrence and recovery. However, despite being incorporated over two decades ago, the company's financial filings explicitly note that the entity has never traded, placing it in the category of a dormant corporate shell rather than an active industry participant.

2. Relative Performance

When measured against typical industry metrics for the UK security systems sector, Selecta DNA Limited's performance is non-existent. Active SMEs in the security installation and services space typically report annual turnovers ranging from £250,000 to £2 million, with gross margins around 30-40% depending on whether the revenue is hardware-driven (lower margin) or service/monitoring-driven (higher margin).

In stark contrast, Selecta DNA has reported £0 turnover for the tracked financial history (2020-2024). Its balance sheet is purely nominal, holding exactly £1,000 in cash and £1,000 in net assets/shareholders' funds, mirroring its £1,000 allotted share capital. With an average employee count of NIL and no operational liabilities or assets, the company fails to register on any conventional industry performance scale, including EBITDA, return on capital employed, or working capital ratios.

3. Sector Trends Impact

The UK security systems sector is currently shaped by several macroeconomic and technological trends from which Selecta DNA is entirely insulated due to its dormant status: * Smart Security & IoT Integration: There is a rapid industry shift towards integrated, cloud-based security systems and IoT-enabled devices. Active firms are heavily investing in R&D and training to transition from traditional alarm systems to smart, remote-monitoring solutions. * Forensic & DNA Marking Demand: The specific sub-niche implied by the company's name—DNA-based asset marking—has seen increased uptake by commercial entities, utilities, and local authorities to combat metal theft and burglary. Police-endorsed marking schemes have driven B2B demand, a market gap this company is missing. * Regulatory Compliance & Cyber Security: Active players are facing rising costs related to GDPR compliance for CCTV data and cybersecurity standards for cloud-connected systems. As a dormant entity, Selecta DNA incurs only the minimal statutory filing costs rather than the heavy compliance overhead typical of the sector.

4. Competitive Positioning

In the context of competitive landscape, Selecta DNA Limited is neither a leader, follower, nor niche player; it is effectively a placeholder entity. * Strengths: Its only strategic advantage is a clean, debt-free balance sheet and a long-established incorporation date (2004), which could theoretically offer some brand longevity or shell-value should the controllers decide to activate the business or sell the entity. * Weaknesses: The company has zero market share, no operational infrastructure, and no brand visibility. In a sector where trust, certification (such as NSI or SSAIB in the UK), and active case studies are critical for winning B2B contracts, Selecta DNA is completely uncompetitive. It is overshadowed by active forensic marking competitors and mainstream security firms that are currently capturing the available market yield.